The invention generally relates to a method for pulmonary delivery of therapeutic, prophylactic and diagnostic agents to a patient wherein the agent is released in a sustained fashion, and to particles suitable for use in the method. In particular, the invention relates to a method for the pulmonary delivery of a therapeutic, prophylactic or diagnostic agent comprising administering to the respiratory tract of a patient in need of treatment, prophylaxis or diagnosis an effective amount of particles comprising a therapeutic, prophylactic or diagnostic agent or any combination thereof in association with a charged lipid, wherein the charged lipid has an overall net charge which is opposite to that of the agent upon association with the agent....
The pulmonary route of drug delivery can provide an excellent alternative to other routes both for l...
The present invention relates to formulations for delivery of drugs to the respiratory tract, especi...
publication date: 2019-05-30; filing date: 2019-01-31The present invention relates to a compound com...
The invention generally relates to a method for pulmonary delivery of therapeutic, prophylactic and ...
Particles incorporating a surfactant and/or a hydrophilic or hydrophobic complex of a positively or ...
Particles incorporating a surfactant and/or a hydrophilic or hydrophobic complex of a positively or ...
This study evaluate the potential of using lipid microparticles as a delivery vehicle for controlled...
Inhalable compositions are described. The inhalable compositions comprise one or more respirable agg...
During the past decade, pulmonary drug delivery (PDD) technology advanced substantially due to sever...
The Pulmonary route has been traditionally used to treat diseases of the respiratory tract. However,...
Drug delivery to the lungs by inhalation offers a targeted drug therapy for respiratory diseases. Ho...
In respiratory drug delivery the lungs or the nose are exploited as absorption sites for the adminis...
The present invention relates to a compound comprising one or more PEG moieties , wherein said compo...
Methods and systems for aerosol delivery of agents to a patient are described herein. The present sy...
The World Health Organisation estimates that 100 million people worldwide suffer from asthma. Chroni...
The pulmonary route of drug delivery can provide an excellent alternative to other routes both for l...
The present invention relates to formulations for delivery of drugs to the respiratory tract, especi...
publication date: 2019-05-30; filing date: 2019-01-31The present invention relates to a compound com...
The invention generally relates to a method for pulmonary delivery of therapeutic, prophylactic and ...
Particles incorporating a surfactant and/or a hydrophilic or hydrophobic complex of a positively or ...
Particles incorporating a surfactant and/or a hydrophilic or hydrophobic complex of a positively or ...
This study evaluate the potential of using lipid microparticles as a delivery vehicle for controlled...
Inhalable compositions are described. The inhalable compositions comprise one or more respirable agg...
During the past decade, pulmonary drug delivery (PDD) technology advanced substantially due to sever...
The Pulmonary route has been traditionally used to treat diseases of the respiratory tract. However,...
Drug delivery to the lungs by inhalation offers a targeted drug therapy for respiratory diseases. Ho...
In respiratory drug delivery the lungs or the nose are exploited as absorption sites for the adminis...
The present invention relates to a compound comprising one or more PEG moieties , wherein said compo...
Methods and systems for aerosol delivery of agents to a patient are described herein. The present sy...
The World Health Organisation estimates that 100 million people worldwide suffer from asthma. Chroni...
The pulmonary route of drug delivery can provide an excellent alternative to other routes both for l...
The present invention relates to formulations for delivery of drugs to the respiratory tract, especi...
publication date: 2019-05-30; filing date: 2019-01-31The present invention relates to a compound com...